SCHEMBL12840363

SCHEMBL12840363

CCCc1nc(-c2ccccc2)cnc1NC(=O)Cc1ccc(O)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
DEGS1 O15121 1/20 0.44
TMIGD3 P0DMS9 1/20 0.44
WNT3A P56704 3/20 0.43
BCHE P06276 2/20 0.42
ACHE P22303 2/20 0.42
RORC P51449 1/20 0.42
ELOVL1 Q9BW60 1/20 0.42
NLRP3 Q96P20 1/20 0.42
ROCK1 Q13464 1/20 0.42
ABL1 P00519 1/20 0.41
APP P05067 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12838488 0.96 DEGS1 (0.47) KMT2AMEN1NPC1RAB9ADEGS1
SCHEMBL12839097 0.94 ROCK1 (0.44) KMT2AMEN1NPC1RAB9ADEGS1
SCHEMBL12839938 0.91 KMT2A (0.48) KMT2AMEN1NPC1RAB9ADEGS1
SCHEMBL12840376 0.90 KMT2A (0.46) KMT2AMEN1NPC1RAB9ATMIGD3
SCHEMBL12840371 0.90 TMIGD3 (0.43) KMT2AMEN1NPC1RAB9ATMIGD3
SCHEMBL12840361 0.90 TMIGD3 (0.43) KMT2AMEN1NPC1RAB9ATMIGD3
SCHEMBL12840364 0.90 KMT2A (0.45) KMT2AMEN1NPC1RAB9ATMIGD3
SCHEMBL12839104 0.89 KMT2A (0.47) KMT2AMEN1NPC1RAB9AWNT3A
SCHEMBL12839096 0.89 ROCK1 (0.40) KMT2AMEN1NPC1RAB9ADEGS1
SCHEMBL12840420 0.89 KMT2A (0.47) KMT2AMEN1NPC1RAB9AWNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 KMT2A 4653/4885MEN1 3926/4885NPC1 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.